Public Health Foundation of India   Report issue

Foundation Phase 3
Founded: Delhi India (2006)

Organization Overview

First Clinical Trial
2010
NCT01057537
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Public Health Foundation of India | Vice President, Research and Policy

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 7